We are live on ! Find out more
BTW

Boston Trust Walden Portfolio holdings

AUM $13.1B
1-Year Est. Return 24.63%
This Fund
S&P 500
This Quarter Est. Return
+7.94%
1 Year Est. Return
+24.63%
3 Year Est. Return
+61.41%
5 Year Est. Return
+82.17%
10 Year Est. Return
+348.28%
AUM
$6.82B
AUM Growth
+$400M
Cap. Flow
-$64.1M
Cap. Flow %
-0.94%
Top 10 Hldgs %
17.87%
Holding
394
New
21
Increased
124
Reduced
197
Closed
10

Top Buys

Rank Stock Value
1
BDX icon
Becton Dickinson
BDX
+$14.8M
2
HSIC icon
Henry Schein
HSIC
+$14.3M
3
HON icon
Honeywell
HON
+$14.2M
4
MD icon
Pediatrix Medical
MD
+$13.5M
5
CRL icon
Charles River Laboratories
CRL
+$13.3M

Top Sells

Rank Stock Value
1
BCR
CR Bard Inc.
BCR
+$62.1M
2
CVS icon
CVS Health
CVS
+$18M
3
ACH
Accendra Health
ACH
+$14.8M
4
UI icon
Ubiquiti
UI
+$13.1M
5
EGBN icon
Eagle Bancorp
EGBN
+$11.4M

Sector Composition

Rank Sector Weight
1 Financials 19.36%
2 Healthcare 15.63%
3 Technology 15.4%
4 Industrials 13.63%
5 Consumer Discretionary 8.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VEU icon
276
Vanguard FTSE All-World ex-US ETF
VEU
$65.6B
$1.99M 0.03%
36,286
+1,700
+5% +$91.4K
DGX icon
277
Quest Diagnostics
DGX
$25.1B
$1.86M 0.03%
18,900
– –
DIS icon
278
Walt Disney
DIS
$165B
$1.76M 0.03%
16,405
-989
-6% -$102K
APH icon
279
Amphenol
APH
$188B
$1.76M 0.03%
80,072
-500
-0.6% -$11K
CSL icon
280
Carlisle Companies
CSL
$13.6B
$1.75M 0.03%
15,400
– –
CDK
281
DELISTED
CDK Global, Inc.
CDK
$1.75M 0.03%
24,484
-355
-1% -$23.8K
CVS icon
282
CVS Health
CVS
$137B
$1.73M 0.03%
23,840
-247,205
-91% -$18M
WFC icon
283
Wells Fargo
WFC
$261B
$1.7M 0.03%
28,067
+480
+2% +$27.1K
BBT
284
Beacon Financial Corp
BBT
$2.53B
$1.66M 0.02%
45,456
-82,500
-64% -$3.14M
SON icon
285
Sonoco
SON
$5.76B
$1.65M 0.02%
31,112
– –
VMBS icon
286
Vanguard Mortgage-Backed Securities ETF
VMBS
$15.4B
$1.56M 0.02%
29,823
+2,100
+8% +$111K
WBA
287
DELISTED
Walgreens Boots Alliance
WBA
$1.56M 0.02%
21,457
+725
+3% +$51.1K
VGK icon
288
Vanguard FTSE Europe ETF
VGK
$30B
$1.5M 0.02%
25,350
-42,500
-63% -$2.48M
QCOM icon
289
Qualcomm
QCOM
$176B
$1.38M 0.02%
21,515
-20,625
-49% -$1.25M
BSV icon
290
Vanguard Short-Term Bond ETF
BSV
$44.6B
$1.35M 0.02%
17,100
-8,500
-33% -$675K
ADBE icon
291
Adobe
ADBE
$89.5B
$1.35M 0.02%
7,690
-50
-0.6% -$8.6K
LH icon
292
Labcorp
LH
$24.3B
$1.35M 0.02%
9,836
-15,894
-62% -$2.1M
WDC icon
293
Western Digital
WDC
$179B
$1.33M 0.02%
22,160
– –
LOW icon
294
Lowe's Companies
LOW
$116B
$1.29M 0.02%
13,882
-200
-1% -$16.5K
META icon
295
Meta Platforms (Facebook)
META
$1.51T
$1.19M 0.02%
6,768
+1,960
+41% +$346K
BMY icon
296
Bristol-Myers Squibb
BMY
$127B
$1.19M 0.02%
19,399
-927
-5% -$58K
CATC
297
DELISTED
CAMBRIDGE BANCORP
CATC
$1.16M 0.02%
+14,550
New +$1.1M
DD icon
298
DuPont de Nemours
DD
$18.6B
$1.14M 0.02%
6,345
+209
+3% +$37.6K
BA icon
299
Boeing
BA
$165B
$1.1M 0.02%
3,725
– –
AMZN icon
300
Amazon
AMZN
$2.5T
$1.09M 0.02%
18,580
+740
+4% +$40.7K
10 11
12
13 14

Similar funds

TWIM
TIAA Wealth Investment Management New York $13.1B AUM
PFPG
Pinnacle Financial Partners (Georgia) Atlanta, Georgia $13.1B AUM
RCMU
Rokos Capital Management (UK) London, United Kingdom $13.2B AUM 85.71% 1-Year Est. Return
EPFB
Employees Provident Fund Board Shah Alam, Malaysia $13.2B AUM 29.65% 1-Year Est. Return
NMIFOAC
National Mutual Insurance Federation of Agricultural Cooperatives Tokyo, Japan, Japan $13B AUM 17.65% 1-Year Est. Return
AAMU
APG Asset Management US New York $13B AUM 5.3% 1-Year Est. Return
MGIA
Moneta Group Investment Advisors St Louis, Missouri $13.3B AUM 18.65% 1-Year Est. Return
TG
TCW Group Los Angeles, California $13.3B AUM 34.44% 1-Year Est. Return

Boston Trust Walden's Q4 2017 Portfolio in Review

As of Q4 2017, Boston Trust Walden held 394 positions worth $6.82B, up 6.2% from $6.42B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Boston Trust Walden's Q4 2017 filing shows 21 new, 124 increased, 197 reduced and 10 closed positions. Its largest new stake was Charles River Laboratories: 122,536 shares worth $13.4M. The largest sale was CR Bard Inc., an estimated $62.1M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 19% a quarter earlier, followed by Healthcare and Technology.

  • Boston Trust Walden's largest Q4 2017 buy was Charles River Laboratories: 122,536 shares worth $13.4M.
  • Boston Trust Walden added most to Becton Dickinson in Q4 2017, an estimated $14.8M increase.
  • Boston Trust Walden's biggest Q4 2017 reduction was CVS Health, cutting an estimated $18M.
  • Boston Trust Walden fully exited CR Bard Inc. in Q4 2017, selling an estimated $62.1M.
  • Boston Trust Walden's ten largest holdings make up 18% of its $6.82B portfolio in Q4 2017.
  • Boston Trust Walden opened 21 new positions and closed 10 in Q4 2017.
  • Boston Trust Walden's portfolio value rose 6.2% quarter-over-quarter to $6.82B.

Based on Boston Trust Walden's 13F filing for Q4 2017, filed 29 Jan 2018.